548 Folgen

  1. How the 21st Century Cures Act Puts Patients at the Table

    Vom: 2.7.2015
  2. Using Cell and Gene Therapies to Treat Rare Skin Diseases

    Vom: 25.6.2015
  3. Incentives Boost Innovation in Rare Disease Therapies

    Vom: 19.6.2015
  4. Tensions Brew Between Pharma and Patient Advocacy Groups

    Vom: 12.6.2015
  5. The Attraction of Being a Rare Disease Drug Company

    Vom: 5.6.2015
  6. Confronting Genetic Destiny in The Lion's Mouth Opens

    Vom: 29.5.2015
  7. Royal Pains Throws Spotlight on Rare Diseases

    Vom: 22.5.2015
  8. Making the Case Rare Diseases are Fundamental

    Vom: 15.5.2015
  9. Programming the Immune System to Produce Drugs

    Vom: 8.5.2015
  10. How One Everyday Superhero Combats Rare Disease

    Vom: 1.5.2015
  11. Terminally Ill Patients Find Hope in Utah's Right to Try Law

    Vom: 24.4.2015
  12. Discovering the Creative Use of Outrage

    Vom: 17.4.2015
  13. New Diagnostic Offers Fast Answers For Group of Rare Diseases

    Vom: 10.4.2015
  14. One Researcher's Effort to Address a Fundamental Challenge in Rare Disease Research

    Vom: 3.4.2015
  15. Turning Lights and Camera into Action: A Mom's Search for Answers

    Vom: 27.3.2015
  16. A Teenager's Transformation from Patient to Advocate

    Vom: 20.3.2015
  17. How the Orphan Drug Act Reshaped the Rare Disease Landscape

    Vom: 13.3.2015
  18. Why the OPEN ACT Could Greatly Expand Treatments for Rare Disease

    Vom: 6.3.2015
  19. Rare Disease Company Seeks 100 Drugs in 10 Years

    Vom: 27.2.2015
  20. A Run Across America to Raise Rare Disease Awareness

    Vom: 20.2.2015

27 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site